Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction

Echocardiography

Volumn 32, Issue 4, 2015, Pages 623-629

  Ishigaki, Takako ^a,b   Yoshida, Takashi ^b   Izumi, Hiromi ^b   Fujisawa, Yoshihisa ^b   Shimizu, Shoko ^b   Masuda, Kasumi ^a   Asanuma, Toshihiko ^a   Okabe, Hidetoshi ^b   Nakatani, Satoshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

B type natriuretic peptide; echocardiography; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; REAL TIME ULTRASOUND SCANNER; SYSTOLIC DYSFUNCTION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD; COMPARATIVE STUDY; COMPLICATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; UPREGULATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; UP-REGULATION; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84926520107     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12707     Document Type: Article

References (30)

1. Cerisano G, Pucci PD, Valenti R, et al. Comparison of the usefulness of Doppler-derived deceleration time versus plasma brain natriuretic peptide to predict left ventricular remodeling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction. Am J Cardiol 2005; 95: 930-934.
2. Logeart D, Saudubray C, Beyne P, et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 2002; 40: 1794-1800.
3. Ammar KA, Paterick TE, Khandheria BK, et al. Myocardial mechanics: Understanding and applying three-dimensional speckle tracking echocardiography in clinical practice. Echocardiography 2012; 29: 861-872.
4. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550.
5. Tokola H, Hautala N, Marttila M, et al. Mechanical load-induced alterations in B-type natriuretic peptide gene expression. Can J Physiol Pharmacol 2001; 79: 646-653.
6. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detection diastolic dysfunction: Comparison with Doppler velocity recording. Circulation 2002; 105: 595-601.
7. Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001; 111: 274-279.
8. Parekh N, Maisel AS,: Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure. Curr Opin Cardiol 2009; 24: 155-160.
9. Troudhton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal braion natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126-1130.
10. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
11. Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-1283.
12. Dirk JV, Gerard CML, Tiny JRN, et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 2013; 61: 1498-1506.
13. Tsutamoto T, Wada A, Sakai H, et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006; 47: 582-586.
14. Troughton RW, Prior DL, Pereira JJ, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: Importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004; 43: 416-422.
15. Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88: 82-91.
16. Wozakowska-Kapłon B, Opolski G, Herman Z, et al. Natriuretic peptides in patients with atrial fibrillation. Cardiol J 2008; 15: 525-529.
17. Maeder MT, Kaye DM,: Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2009; 53: 905-918.
18. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133.
19. Sengupta PP, Krishnamoorthy VK, Korinek J, et al. Left ventricular form and function revisited: Applied translational science to cardiovascular ultrasound imaging. J Am Soc Echocardiogr 2007; 20: 539-551.
20. Jones CJ, Raposo L, Gibson DG,: Functional importance of the long axis dynamics of human left ventricle. Br Heart J 1990; 63: 215-220.
21. Stanton T, Leano R, Marwick TH,: Prediction of all-cause mortality from global longitudinal speckle strain:Comparison with ejection fraction and wall motion scoreing. Circ Cardiovasc Imaging 2009; 2: 356-364.
22. Cho GY, Marwick TH, Kim HS, et al. Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 2009; 54: 618-624.
23. Reant P, Labrousse L, Lafitte S, et al. Experimental validation of circumferential, longitudinal, and radial 2-dimensional strain during dobutamine stress echocardiography in ischemic conditions. J Am Coll Cardiol 2008; 51: 149-157.
24. Mullens W, Borowski AG, Curtin RJ, et al. Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation 2009; 119: 62-70.
25. Takigiku K, Takeuchi M, Izumi C, et al. Normal range of left ventricular 2-dimensional strain, Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE) Study. Cir J 2012; 76: 2623-2632.
26. Nakatani S,: Left ventricular rotation and twist: Why should we learn? J Cardiovasc Ultrasound 2011; 19: 1-6.
27. Sengupta PP, Tajik AJ, Chandrasekran K, et al. Twist mechanics of the left ventricle: Principles and application. J Am Coll Cardiol Img 2008; 1: 366-376.
28. Biswas M, Sudhakar S, Nanda NC, et al. Two- and three-dimensional speckle tracking echocardiography: Clinical applications and future directions. Echocardiography 2013; 30: 88-105.
29. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.
30. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600.